These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2664391)

  • 1. What is the relationship between the endothelium derived relaxant factor and nitric oxide?
    Long CJ; Berkowitz BA
    Life Sci; 1989; 45(1):1-14. PubMed ID: 2664391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-derived nitric oxide relaxes nonvascular smooth muscle.
    Buga GM; Gold ME; Wood KS; Chaudhuri G; Ignarro LJ
    Eur J Pharmacol; 1989 Feb; 161(1):61-72. PubMed ID: 2542037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of haemoglobin and erythrocytes on the effects of EDRF, a smooth muscle inhibitory factor, and nitric oxide on vascular and non-vascular smooth muscle.
    Gillespie JS; Sheng H
    Br J Pharmacol; 1988 Dec; 95(4):1151-6. PubMed ID: 3265343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
    Shikano K; Berkowitz BA
    J Pharmacol Exp Ther; 1987 Oct; 243(1):55-60. PubMed ID: 3499504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.
    Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Vane JR
    Br J Pharmacol; 1992 Dec; 107(4):1001-7. PubMed ID: 1281716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of NO and EDRF from cultured bovine aortic endothelial cells.
    Myers PR; Guerra R; Harrison DG
    Am J Physiol; 1989 Apr; 256(4 Pt 2):H1030-7. PubMed ID: 2784944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.
    Ignarro LJ; Buga GM; Byrns RE; Wood KS; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Jul; 246(1):218-26. PubMed ID: 2839663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium-derived hyperpolarizing factor and endothelium-dependent relaxations.
    Nagao T; Vanhoutte PM
    Am J Respir Cell Mol Biol; 1993 Jan; 8(1):1-6. PubMed ID: 8380248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells.
    Kelm M; Feelisch M; Spahr R; Piper HM; Noack E; Schrader J
    Biochem Biophys Res Commun; 1988 Jul; 154(1):236-44. PubMed ID: 3260776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery of nitric oxide as the endogenous nitrovasodilator.
    Moncada S; Palmer RM; Higgs EA
    Hypertension; 1988 Oct; 12(4):365-72. PubMed ID: 3049340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysolecithins as endothelium-dependent vascular smooth muscle relaxants that differ from endothelium-derived relaxing factor (nitric oxide).
    Saito T; Wolf A; Menon NK; Saeed M; Alves C; Bing RJ
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8246-50. PubMed ID: 3263649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent advances in EDRF research].
    Shikano K
    Nihon Rinsho; 1992 Jun; 50(6):1430-6. PubMed ID: 1518161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacology of endothelium-derived relaxing factor and nitric oxide.
    Shikano K; Long CJ; Ohlstein EH; Berkowitz BA
    J Pharmacol Exp Ther; 1988 Dec; 247(3):873-81. PubMed ID: 2849673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EDRF and nitric oxide production in cultured endothelial cells: direct inhibition by E. coli endotoxin.
    Myers PR; Wright TF; Tanner MA; Adams HR
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H710-8. PubMed ID: 1558180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superoxide dismutase does not improve penetration of endothelium-derived relaxing factor (EDRF) through the vessel wall.
    Gräser T; Vedernikov YP
    Biomed Biochim Acta; 1989; 48(4):351-3. PubMed ID: 2787633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular smooth muscle and nitric oxide.
    Zehetgruber M; Conforto A; Bing RJ
    Life Sci; 1993; 52(17):1397-406. PubMed ID: 8464341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of calcium channel blockade and intracellular calcium antagonism on endothelium-dependent responses of the rat aorta to drugs.
    Olah ME; Rahwan RG
    Pharmacology; 1988; 37(5):305-20. PubMed ID: 3266338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the survival of endothelium-derived relaxing factor and nitric oxide within the isolated perfused mesenteric arterial bed of the rat.
    Warner TD; de Nucci G; Vane JR
    Br J Pharmacol; 1989 Jul; 97(3):777-82. PubMed ID: 2503227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar responsiveness of smooth muscle of the canine basilar artery to EDRF and nitric oxide.
    Katusic ZS; Marshall JJ; Kontos HA; Vanhoutte PM
    Am J Physiol; 1989 Oct; 257(4 Pt 2):H1235-9. PubMed ID: 2552840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine and paracrine actions of EDRF on intracellular Ca2+ of endothelial cells and vascular smooth muscle cells as identified by two-D image analysis.
    Toyo-oka T; Shin WS; Sasaki T; Kato M; Sugimoto T
    Jpn J Pharmacol; 1992; 58 Suppl 2():323P. PubMed ID: 1507579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.